Free Access
| Issue |
Med Sci (Paris)
Volume 35, Mars 2019
JRC 2018 – Innovation et parcours de soins
|
|
|---|---|---|
| Page(s) | 54 - 56 | |
| Section | Les ateliers JRC 2018 | |
| DOI | https://doi.org/10.1051/medsci/2019053 | |
| Published online | 03 April 2019 | |
- Société de Pneumologie de Langue Française Recommandations pour la pratique clinique concernant les explorations fonctionnelles respiratoires 2008–2010. Rev Mal Respir 2011 ; 28 : 1183–1192. [CrossRef] [PubMed] [Google Scholar]
- van der Ploeg AT, Clemens PR, Corzo D, et al. A randomized study of alglucosidase alfa in late-onset Pompe’s disease. N Engl J Med 2010 ; 362 : 1396–1406. [Google Scholar]
- Buyse GM, Voit T, Schara U, et al. Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial. Lancet 2015 ; 385 : 1748–1757. [CrossRef] [PubMed] [Google Scholar]
- Jimenez-Moreno AC, Newman J, Charman SJ, et al. Measuring habitual physical activity in neuromuscular disorders: a systematic review. J Neuromuscul Dis 2017 ; 4 : 25–52. [CrossRef] [PubMed] [Google Scholar]
- Bachasson D, Landon-Cardinal O, Benveniste O, et al. Physical activity monitoring: A promising outcome measure in idiopathic inflammatory myopathies. Neurology 2017 ; 89 : 101–103. [Google Scholar]
- Bassez G, Audureau E, Hogrel JY, et al. Improved mobility with metformin in patients with myotonic dystrophy type 1: a randomized controlled trial. Brain 2018 ; 141 : 2855–2865. [CrossRef] [PubMed] [Google Scholar]
- Laforêt P, Laloui K, Granger B, et al. The French Pompe registry. Baseline characteristics of a cohort of 126 patients with adult Pompe disease. Rev Neurol (Paris) 2013 ; 169 : 595–602. [CrossRef] [PubMed] [Google Scholar]
- Papadopoulos C, Orlikowski D, Prigent H, et al. Effect of enzyme replacement therapy with alglucosidase alfa (Myozyme®) in 12 patients with advanced late-onset Pompe disease. Mol Genet Metab 2017 ; 122 : 80–85. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.